Novavax Jumps on $388 Million Funding From Vaccine Coalition

(Bloomberg) -- Novavax Inc. rallied 20% in after hours trading on Monday after its experimental vaccine for the pandemic sweeping across the globe got a major infusion of cash.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.